SMTL ID : 2gby.4 (3 other biounits)

Structure of QacR Multidrug Transcriptional Regulator Bound to Bivalent Diamidine Berenil

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-16-mer

Ligands

4 x BRN: BERENIL(Non-covalent)

BRN.1: 11 residues within 4Å: Chain A: F.162, E.165, Q.166 Chain B: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 8 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:Y.103, B:E.120, B:E.120, B:I.124, A:F.162, A:F.162, A:F.162 Hydrogen bonds: B:I.99, B:E.120, B:N.154, B:N.157, A:Q.166 BRN.8: 11 residues within 4Å: Chain C: F.162, E.165, Q.166 Chain D: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 8 interactions with chain D, 4 interactions with chain C Hydrophobic interactions: D:Y.103, D:E.120, D:E.120, D:I.124, C:F.162, C:F.162, C:F.162 Hydrogen bonds: D:I.99, D:E.120, D:N.154, D:N.157, C:Q.166 BRN.15: 11 residues within 4Å: Chain E: F.162, E.165, Q.166 Chain F: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 8 interactions with chain F, 4 interactions with chain E Hydrophobic interactions: F:Y.103, F:E.120, F:E.120, F:I.124, E:F.162, E:F.162, E:F.162 Hydrogen bonds: F:I.99, F:E.120, F:N.154, F:N.157, E:Q.166 BRN.22: 11 residues within 4Å: Chain G: F.162, E.165, Q.166 Chain H: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 8 interactions with chain H, 4 interactions with chain G Hydrophobic interactions: H:Y.103, H:E.120, H:E.120, H:I.124, G:F.162, G:F.162, G:F.162 Hydrogen bonds: H:I.99, H:E.120, H:N.154, H:N.157, G:Q.166

44 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain B: N.2, D.5, K.6 Ligand excluded by PLIP SO4.3: 3 residues within 4Å: Chain B: K.4, Y.41, H.42 Ligand excluded by PLIP SO4.4: 4 residues within 4Å: Chain B: V.29, S.35, K.36, G.37 Ligand excluded by PLIP SO4.5: 4 residues within 4Å: Chain B: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.6: 2 residues within 4Å: Chain B: H.128, K.132 Ligand excluded by PLIP SO4.7: 5 residues within 4Å: Chain B: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.9: 3 residues within 4Å: Chain D: N.2, D.5, K.6 Ligand excluded by PLIP SO4.10: 3 residues within 4Å: Chain D: K.4, Y.41, H.42 Ligand excluded by PLIP SO4.11: 4 residues within 4Å: Chain D: V.29, S.35, K.36, G.37 Ligand excluded by PLIP SO4.12: 4 residues within 4Å: Chain D: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.13: 2 residues within 4Å: Chain D: H.128, K.132 Ligand excluded by PLIP SO4.14: 5 residues within 4Å: Chain D: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.16: 3 residues within 4Å: Chain F: N.2, D.5, K.6 Ligand excluded by PLIP SO4.17: 3 residues within 4Å: Chain F: K.4, Y.41, H.42 Ligand excluded by PLIP SO4.18: 4 residues within 4Å: Chain F: V.29, S.35, K.36, G.37 Ligand excluded by PLIP SO4.19: 4 residues within 4Å: Chain F: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.20: 2 residues within 4Å: Chain F: H.128, K.132 Ligand excluded by PLIP SO4.21: 5 residues within 4Å: Chain F: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.23: 3 residues within 4Å: Chain H: N.2, D.5, K.6 Ligand excluded by PLIP SO4.24: 3 residues within 4Å: Chain H: K.4, Y.41, H.42 Ligand excluded by PLIP SO4.25: 4 residues within 4Å: Chain H: V.29, S.35, K.36, G.37 Ligand excluded by PLIP SO4.26: 4 residues within 4Å: Chain H: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.27: 2 residues within 4Å: Chain H: H.128, K.132 Ligand excluded by PLIP SO4.28: 5 residues within 4Å: Chain H: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.29: 4 residues within 4Å: Chain I: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.30: 4 residues within 4Å: Chain I: E.13, I.16 Chain M: K.30, E.33 Ligand excluded by PLIP SO4.31: 4 residues within 4Å: Chain J: Y.40, T.45, K.46 Chain N: K.36 Ligand excluded by PLIP SO4.32: 5 residues within 4Å: Chain J: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.33: 3 residues within 4Å: Chain J: N.2, D.5, K.6 Ligand excluded by PLIP SO4.34: 4 residues within 4Å: Chain K: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.35: 4 residues within 4Å: Chain K: E.13, I.16 Chain O: K.30, E.33 Ligand excluded by PLIP SO4.36: 4 residues within 4Å: Chain L: Y.40, T.45, K.46 Chain P: K.36 Ligand excluded by PLIP SO4.37: 5 residues within 4Å: Chain L: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.38: 3 residues within 4Å: Chain L: N.2, D.5, K.6 Ligand excluded by PLIP SO4.39: 4 residues within 4Å: Chain M: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.40: 4 residues within 4Å: Chain I: K.30, E.33 Chain M: E.13, I.16 Ligand excluded by PLIP SO4.41: 4 residues within 4Å: Chain J: K.36 Chain N: Y.40, T.45, K.46 Ligand excluded by PLIP SO4.42: 5 residues within 4Å: Chain N: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.43: 3 residues within 4Å: Chain N: N.2, D.5, K.6 Ligand excluded by PLIP SO4.44: 4 residues within 4Å: Chain O: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.45: 4 residues within 4Å: Chain K: K.30, E.33 Chain O: E.13, I.16 Ligand excluded by PLIP SO4.46: 4 residues within 4Å: Chain L: K.36 Chain P: Y.40, T.45, K.46 Ligand excluded by PLIP SO4.47: 5 residues within 4Å: Chain P: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.48: 3 residues within 4Å: Chain P: N.2, D.5, K.6 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brennan, R.G. et al., Structure of QacR Multidrug Transcriptional Regulator Bound to Trivalent and Bivalent Diamidine Drugs. To be Published

Release Date

2008-04-08

Peptides

HTH-type transcriptional regulator qacR: ABCDEFGHIJKLMNOP

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
A

C
B

D
A

E
B

F
A

G
B

H
A

I
D

J
E

K
D

L
E

M
D

N
E

O
D

P
E

HTH-type transcriptional regulator qacR

Related Entries With Identical Sequence